Femara Oral Anabolic Steroids Letrozole For Breast Cancer Treatment CAS 112809-51-5

Femara(Letrozole) is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery. The anti-estrogen action of Femara has been shown to be useful in pretreatment for termination of pregnancy, in combination with misoprostol. It can be used in place of mifepristone, which is expensive and unavailable in many countries.

Femara Oral Anabolic Steroids Letrozole For Breast Cancer Treatment CAS 112809-51-5

Descriptions of Femara:

1. Femara is a powerful Aromatase Inhibitor that was developed to fight breast cancer.

2. For athletes and bodybuilders, Femara is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia.

3. Femara will also raise testosterone levels because of the lowered estrogen in the body.

4. Femara is a new drug developed for the treatment of advanced breast cancer in women.

5. Femara is the second in a new class of third-generation selective oral aromatase inhibitors.

6. Femara acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen.

Applications:

Benefits of Femara for women breast cancer

Two large studies have shown the benefits of Femara.

The international BIG 1-98 trial, started in 1998, compared Femara to tamoxifen after surgery in postmenopausal women diagnosed with hormone-receptor-positive, early-stage breast cancer. The results showed that Femara was better than tamoxifen for:

increasing the time before the cancer comes back in those who experience recurrence

reducing the risk of the cancer spreading to other parts of the body

The MA-17 study, conducted in Canada, looked at whether taking Femara for 5 years AFTER taking tamoxifen for 5 years (for a total of 10 years of hormonal therapy) could lower the risk of the cancer coming back in postmenopausal women diagnosed with hormone-receptor-positive, early-stage breast cancer. The results showed that Femara:

reduced the risk of the cancer coming back

reduced the risk of the cancer spreading to another part of the body

compared to not taking Femara after 5 years of tamoxifen.

Femara usages:

1. Femara (letrozole) is a type II (non-steroidal) third generation aromatase inhibitor. Clinically it is used to treat postmenopausal women with either estrogen receptor positive or estrogen receptor unknown breast cancer.

In women with breast cancer, it has been shown to reduce estrogen levels by 98% or more. However, it’s use and benefits are not limited to eliminating estrogen in women.

For pre-contest bodybuilders, Letrozole is almost a necessity to eliminate water retention and achieve the ripped look necessary to compete in today’s bodybuilding world. However, in my experience, it is only necessary to be used for the last 4-6 weeks, to eliminate excess estrogen and water retention.

After using Femara, I recommend staying away from any estrogen suppression for at least a month to try to normalize the body.

2. Femara is used to treat postmenopausal women with hormone receptor positive early breast cancer or who have been treated with tamoxifen (Nolvadex). It also is approved for initial or second-line treatment of postmenopausal women with hormone-sensitive or advanced breast cancer.

Featured Service:

Price: Fair and Competitive

Package: Discreet and disguised. Detailed things can be discussed via email.

Shipping methods: We can take different shipping ways for different quantities and different countries.

Other Service: Parcel picture, tracking number and tracking website can be offered after shipment.

Customs Rate: 99.9% success rate. If seized, it will be re-shipped for you.